AwardedUnited KingdomServices£140,671
Blood Group Genotyping for Sickle Cell and Thalassaemi
- Published
- Published 3 September 2025
- Deadline
- Closed 5 May 2025
Overview
The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.
Key details
- Country
- United Kingdom
- Status
- Awarded
- Category
- Services
- Estimated value
- £140,671
- SME suitable
- Yes
- Published
- 3 September 2025
- Deadline
- Closed
Blood analysis services
Award outcome
- Awarded value
- £140,671
- Award date
- 12 May 2025
- Contract period
- 11 May 2025 → 31 March 2026
- NHS BLOOD AND TRANSPLANT (NHSBT)
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 September 2025
Contracting authority
NHS England, Leeds
BuyerLeeds, United Kingdom
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.